4basebio provides Phi29 DNA polymerase variants and expertise to develop improved detection system for SARS-CoV-2 infection

CENTOGENE Releases a New Swab Product to Facilitate the Simple Diagnosis of COVID-19

CENTOGENE AG: „Mittelstandsinitiative COVID-19“ zur Bekämpfung des Corona-Virus zeigt Wirkung

Adocia to hold its annual shareholders’ meeting on May 28th, 2020 at its headquarter in Lyon

CENTOGENE and Ubirch Create Secure Blockchain Solution for the Successful Fight Against COVID-19

CEVEC signs license agreement for the development and commercialization of exosomes for therapeutic use

Newron Receives Third Tranche from Financing Agreement with European Investment Bank (EIB)

CENTOGENE AG: Corona-Testergebnisse zukünftig in der Blockchain verankert – CENTOGENE und Ubirch schaffen sichere Lösung für den erfolgreichen Kampf gegen COVID-19

CENTOGENE AG: CENTOGENE gibt die Eröffnung eines Labors in Hamburg (Deutschland) bekannt

Adocia announces first quarter 2020 financial results and update on the impact of COVID-19